Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Ocean Biomedical Inc.

OCEA
Current price
0.76 USD -0.05 USD (-6.17%)
Last closed 0.82 USD
Company
ISIN US67644C1045
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 28 422 574 USD
Yield for 12 month -48.12 %
1Y
3Y
5Y
10Y
15Y
OCEA
21.11.2021 - 28.11.2021

Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP. The company is based in Providence, Rhode Island. Ocean Biomedical, Inc. operates as a subsidiary of Poseidon Bio, LLC. Address: Room 325, 55 Claverick Street, Providence, RI, United States, 02903

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

18.5 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures OCEA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA
Operating Margin TTM
PE Ratio
Return On Assets TTM -681.99 %
PEG Ratio
Return On Equity TTM
Wall Street Target Price 18.5 USD
Revenue TTM
Book Value -2.21 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -3 USD
Diluted Eps TTM -3 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics OCEA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History OCEA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation OCEA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -9.4827
Price Book MRQ 100.6724

Financials OCEA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators OCEA

For 52 weeks

0.52 USD 7.79 USD
50 Day MA 0.95 USD
Shares Short Prior Month 183 682
200 Day MA 1.54 USD
Short Ratio 3.62
Shares Short 159 200
Short Percent 1.56 %